Does aberrant Methylation of FOXE1 contribute to a Poor Prognosis for Patients with Colorectal Cancer?
Methylation-mediated silencing of FOXE1 expression was shown to be a potential prognostic factor in CRC.
Our analysis clearly demonstrates for the first time an additional benefit of FA for adjuvant treatment of elderly CC patients. We conclude that this regimen is very safe and effective for adjuvant treatment of elderly patients.